TITLE OF INVENTION ELECTROSTATICALLY CHARGED MASK FILTER PRODUCTS AND METHOD FOR INCREASED FILTRATION EFFICIENCY CROSS REFERENCE TO RELATED APPLICATIONS a) The Present Application is the PCT international non-provisional counterpart of US Provisional Application Serial No. US 61/091 ,931 filed on 26 August 2008 which is incorporated by reference in its entirety herein. The Present Application claims the benefit of and priority to said US Provisional Application. b) The Present Application is a PCT international continuation of my pending US Patent Application Serial No. US 12/475,690 filed on 1 June 2009 which is incorporated by reference in its entirety herein. The Present Application claims the benefit of and priority to said US non-provisional patent application. FIELD OF THE INVENTION The Present Invention relates to the field of surgical and other permeable masks that are used to reduce transmission of airborne particulates and harmful airborne contaminants. It also relates to the field of electrostatic compositions that protect against the same harmful contaminants. BACKGROUND OF THE INVENTION Healthcare professionals, personnel and visitors to such facilities as well as patients are particularly susceptible to infections spread by harmful contaminants found in operating rooms and other hospital facilities. Consequently, doctors and nurses employ a sterilization procedure and wear protective gear so as to prevent contaminants from their own bodies being transmitted to patients thereby infecting them. Surgical masks are worn by hospital personnel to prevent their own bacterial organisms from being transmitted to patients by respiratory secretions. Many other people wear surgical or other permeable masks. People with colds, particularly in Asian countries, wear these masks to avoid infecting others. Conversely, during times of airborne epidemics, many people wear the masks to avoid infection. Still others wear the masks in dusty environments to avoid inhaling the dust. The Present Applicant has previously invented products and methods for restricting the flow of airborne contaminants into the nasal passages by creating an electrostatic field in an area near about the nasal passages. This reduced the inflow of airborne contaminants to the nasal passages by capturing these contaminants and keeping them from entering the body. These products and methods can be found in the Present Applicant's US patents and US provisional applications that have been incorporated by reference into the Present Application. SUMMARY OF THE INVENTION Surgical and other permeable masks are used to stop contaminants from entering the mouth and nose of people administering healthcare or working in other areas where there is a danger of having dangerous particles enter the oral and nasal passages. These masks, however, have pores that can still allow the smallest particles to pass through them. The Present Invention applies an electrostatic charge to the mask wherein said charge will reduce and/or eliminate this risk, by capturing oppositely charged contaminants ranging in size from 0 to 30 microns. DETAILED DESCRIPTION OF THE INVENTION Various cationic and anionic liquids are known in the art which create an electrostatic field when applied to a surface. Some were described in the Present Applicant's US Patents Serial Nos. 5,468,488 (issued on November 21 , 1995), 5,674,481 (issued on October 7, 1997), and 6,844,005 (issued on January 18, 2005). Depending upon specific contaminants from which protection is sought, the fabric of the mask is coated with one of these liquid or semi-solid products. After application, the coating is dried completely or semi-dried. It may also be allowed to remain wet. After application of the coating, these products provide an electrostatic field around the mask which either repels similarly charged particulates or attracts oppositely charged contaminant particles. Those contaminant particles that are brought to the mask bind to the fabric through electrostatic attraction. They do not travel away from the mask. Therefore, these outside airborne contaminants that are attracted to the mask do not enter the mask wearer's nose or mouth, and these contaminants that are attracted to the mask and are expelled from the wearer's nose or mouth do not travel beyond the mask even though they might be smaller than the permeable openings in the mask. On the other hand, those particles that are repelled from the mask will not pass through the mask in either direction regardless of size. There are several ways to fabricate the above product all essentially with the primary objective of increasing the filtration efficiency of the mask. • The fabric used to make the mask can itself be coated with the cationic or anionic agent, which dries and becomes part of the fabric. • The material used to make a non-fabric mask can be coated with the cationic or anionic agent, which dries and becomes part of the material. • The finished mask itself may be coated with the cationic or anionic agent which, dries and becomes part of the mask prior to its packaging. • The cationic or anionic agent may be distributed in a bottle having an aerosol spray or pump action for "point of use" for any mask. This agent may be applied to the mask by the user just prior to use to enhance efficacy. A formulation of the invention comprises: • at least one quaternary conditioner; • a humectant; • a preservative; • a biocidic agent, and • a neutralizing agent added to adjust and achieve a pH in the range of 5.0 tO 6.8. It may also further comprise an emollient and/or a surfactant and/or a chelating agent. The formulation may either have an aqueous or non- aqueous base. Therefore, an embodiment of the formulation may also comprise water. In an exemplary embodiment of such a formulation, the amount of water may range from 64% to 77% by weight; quaternary conditioner (at least one must be present) - 0.4% to 18% by weight; humectant - 8% to 11 % by weight; emollient - 3% to 6% by weight; preservative - 0.3% by weight; and biocidic agent - 0.2% to 0.5% by weight. In an exemplary embodiment of such a formulation, a quaternary conditioner may comprise, without limitation, a least one of the following: • Polyquaternium-6 • Polyquaternium-7 • Polyquaternium-10 • Polyquaternuim-22 • Polyquaternium-70 • Merquat 280 • Merquat 10 • Merquat 5 • Cocodimonium, Hydroxypropyl, Hydrolyzed Keratin • Quaternized Oat, Hydrolyzed Oat Protein • Benzylkonium Chloride. In an exemplary embodiment of such a formulation, a humectant may comprise, without limitation Glycerin or Acetamide MEA. Also, in an exemplary embodiment, an emollient may comprise, without limitation Dipropylene Glycol. Further, in an exemplary embodiment, a surfactant may comprise, without limitation, Octoxynol-9. In addition, a chelating agent may comprise, without limitation, Tetrasodium EDTA. Finally, in an exemplary embodiment, a biocidic agent may comprise, without limitation, Lysine HCL. In an exemplary embodiment of such a formulation, a preservative may comprise, without limitation: • Phenoxyethanol • Caprylyl Glycol • Sorbic Acid • Gluconolactone • Sodium Benzoate • Methylparaben • Ethylparaben In an exemplary embodiment of the formulation: a) the amount of water in the formulation ranges from 25% to 95% by weight; b) the amount of the at least one quaternary conditioner in the formulation ranges from 0.4% to 18% by weight; c) the amount of the humectant in the formulation ranges from 1 % to 11 % by weight; d) the amount of the emollient in the formulation ranges from 1 % to 8% by weight; e) the amount of the preservative in the formulation is 0.3% by weight; and f) the amount of the biocidic agent in the formulation ranges from 0.1 % to 0.5% by weight.

Examples of typical formulations appear in Tables 1 -10 (infra):

TABLE 3

TABLE 6